Inari Medical, Inc.

NasdaqGS NARI

Inari Medical, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2024: USD -1.76 M

Inari Medical, Inc. Net Cash Used Provided By Financing Activities is USD -1.76 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -193.13% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Inari Medical, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 1.89 M, a -98.94% change year over year.
  • Inari Medical, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 178.21 M, a 3,522.83% change year over year.
  • Inari Medical, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 4.92 M, a -96.80% change year over year.
  • Inari Medical, Inc. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 153.91 M.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
NasdaqGS: NARI

Inari Medical, Inc.

CEO Mr. Andrew J. Hykes
IPO Date May 22, 2020
Location United States
Headquarters 6001 Oak Canyon
Employees 1,300
Sector Health Care
Industries
Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Similar companies

OM

Outset Medical, Inc.

USD 0.81

0.53%

LEGN

Legend Biotech Corporation

USD 31.64

-2.65%

PGNY

Progyny, Inc.

USD 20.04

-1.28%

StockViz Staff

January 15, 2025

Any question? Send us an email